These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6994770

  • 1. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.
    Jerie P.
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770
    [Abstract] [Full Text] [Related]

  • 2. Comparison of guanfacine and clonidine as antihypertensive agents.
    Jäättelä A.
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6994782
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience with guanfacine in long-term treatment of hypertension.
    Jerie P.
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):37S-47S. PubMed ID: 6994777
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
    Distler A, Kirch W, Lüth B.
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Minimal useful dose of guanfacine in patients with essential hypertension].
    Pérez Olea J, Ortíz N, Soledad Bertoló M, Allel L, Goity C, Quevedo M.
    Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
    [No Abstract] [Full Text] [Related]

  • 13. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
    MacCarthy P, Isaac P, Frost G, Freeman A, Stokes G.
    Clin Exp Pharmacol Physiol; 1978 May; 5(2):187-90. PubMed ID: 348364
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of long-term treatment of essential hypertension with guanfacine.
    Higuchi M, Overlack A, Stumpe KO.
    Br J Clin Pharmacol; 1980 May; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
    [Abstract] [Full Text] [Related]

  • 15. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
    Mayer O, Polívková H.
    Cor Vasa; 1987 May; 29(4 Suppl 1):37-41. PubMed ID: 3315449
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Guanfacine for hypertension.
    Med Lett Drugs Ther; 1987 May 22; 29(740):49-50. PubMed ID: 2883560
    [No Abstract] [Full Text] [Related]

  • 18. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar 22; 22(3):170-4. PubMed ID: 6370876
    [Abstract] [Full Text] [Related]

  • 19. [A new antihypertensive agent used in a clinical setting].
    Wetzels E, Raschig A, Kaiser HJ.
    Med Klin; 1980 Sep 12; 75(19):688-92. PubMed ID: 7001207
    [Abstract] [Full Text] [Related]

  • 20. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N, Knaup G.
    Med Welt; 1983 Feb 04; 34(5):158-61. PubMed ID: 6341756
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.